Authors:
Lockman, S
Kruuner, A
Binkin, NJ
Levina, K
Wang, YC
Danilovitsh, M
Hoffner, SE
Tappero, HW
Citation: S. Lockman et al., Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis, CLIN INF D, 32(3), 2001, pp. 373-380
Authors:
Abate, G
Hoffner, SE
Thomsen, VO
Miorner, H
Citation: G. Abate et al., Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG, EUR J CL M, 20(5), 2001, pp. 329-333
Authors:
Ramasoota, P
Chansiripornchai, N
Kallenius, G
Hoffner, SE
Svenson, SB
Citation: P. Ramasoota et al., Comparison of Mycobacterium avium complex (MAC) strains from pigs and humans in Sweden by random amplified polymorphic DNA (RAPD) using standardized reagents, VET MICROB, 78(3), 2001, pp. 251-259
Authors:
Linde, CMA
Hoffner, SE
Refai, E
Andersson, M
Citation: Cma. Linde et al., In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis, J ANTIMICRO, 47(5), 2001, pp. 575-580
Authors:
Werngren, J
Olsson-Liljequist, B
Gezelius, L
Hoffner, SE
Citation: J. Werngren et al., Antimicrobial susceptibility of Mycobacterium marinum determined by E-testand agar dilution, SC J IN DIS, 33(8), 2001, pp. 585-588
Authors:
Schwoebel, V
Lambregts-van Weezenbeek, CSB
Moro, ML
Drobniewski, F
Hoffner, SE
Raviglione, MC
Rieder, HL
Citation: V. Schwoebel et al., Standardization of antituberculosis drug resistance surveillance in Europe- Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group, EUR RESP J, 16(2), 2000, pp. 364-371
Authors:
Kallenius, G
Koivula, T
Ghebremichael, S
Hoffner, SE
Norberg, R
Svensson, E
Dias, F
Marklund, BI
Svenson, SB
Citation: G. Kallenius et al., Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau, J CLIN MICR, 37(12), 1999, pp. 3872-3878